Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

201
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
201
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

183
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
183
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

3.6K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

131
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
131

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is abnormal brain insulin action implicated in the biology of depression? A pilot neuroimaging study in adolescents.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same author

Pharmacological Interventions for Weight Reduction in Patients With Schizophrenia Treated With Antipsychotics: A Systematic Review and Network Meta-Analysis.

JAMA psychiatry·2026
Same author

The Effect of Semaglutide on Antipsychotic-Induced Weight Gain and Other Metabolic Parameters, among a Cohort of Inpatients.

Schizophrenia bulletin·2026
Same author

Real-World Clinical Datasets in Practice: Applications for Learners, Clinician-Educators, and Health Services Teams.

Clinical and translational science·2026
Same author

Longitudinal wastewater-based surveillance of vancomycin-resistant Enterococci in tertiary-care hospitals.

The Science of the total environment·2026
Same author

A novel interoceptive subfornical organ to infralimbic cortex mechanism relays airway inflammation effects on fear extinction.

Journal of neuroinflammation·2026

Related Experiment Video

Updated: Jul 3, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

54

Olanzapine's effects on hypothalamic transcriptomics and kinase activity.

Sandra Pereira1, Laura N Castellani2, Chantel Kowalchuk2

  • 1Centre for Addiction and Mental Health, Toronto, ON, Canada; Department of Physiology, University of Toronto, Toronto, ON, Canada.

Psychoneuroendocrinology
|February 10, 2024
PubMed
Summary

Second-generation antipsychotic olanzapine disrupts metabolism, increasing type 2 diabetes risk. This study reveals olanzapine impacts hypothalamic pathways, offering potential targets to mitigate metabolic side effects in patients.

Keywords:
Kinome arrayOlanzapineRNA-seq

More Related Videos

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
07:58

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Published on: February 24, 2023

517
Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

6.9K

Related Experiment Videos

Last Updated: Jul 3, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

54
Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
07:58

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Published on: February 24, 2023

517
Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

6.9K

Area of Science:

  • Neuroscience
  • Metabolic research
  • Pharmacology

Background:

  • Olanzapine, a second-generation antipsychotic, is linked to metabolic disruption and increased type 2 diabetes risk.
  • The hypothalamus plays a crucial role in regulating whole-body metabolic homeostasis.
  • Understanding olanzapine's central effects on the hypothalamus is vital for managing its metabolic side effects.

Purpose of the Study:

  • To investigate the effects of acute peripheral olanzapine administration on hypothalamic transcription and serine/threonine kinase activity.
  • To identify specific molecular pathways affected by olanzapine in the hypothalamus under controlled metabolic conditions.

Main Methods:

  • Utilized the pancreatic euglycemic clamp technique in rats to maintain steady-state plasma glucose and insulin levels.
  • Collected hypothalamic samples for transcriptional and kinase activity analysis following acute olanzapine administration.

Main Results:

  • Olanzapine administration stimulated inflammatory pathways within the hypothalamus.
  • Conversely, olanzapine diminished pathways involved in combating endoplasmic reticulum stress.
  • Activity in G protein-coupled receptor pathways was also reduced by olanzapine.

Conclusions:

  • Acute olanzapine exposure alters key hypothalamic pathways related to inflammation and cellular stress response.
  • These identified pathways represent potential therapeutic targets for reducing the incidence of type 2 diabetes in patients using antipsychotics.
  • Further research into modulating these pathways could improve metabolic safety profiles of antipsychotic medications.